ClinicalTrials.Veeva

Menu

Molecular Characterization of Blastocystis Isolates From Human by Restriction Fragment Length Polymorphism (RFLP) Analysis

S

Sohag University

Status

Not yet enrolling

Conditions

Blastocystis Infections

Treatments

Diagnostic Test: RFLP analysis of SSU rRNA

Study type

Observational

Funder types

Other

Identifiers

NCT05580393
Soh-Med-22-10-16

Details and patient eligibility

About

Blastocystis is an anaerobic unicellular protozoal parasite infecting the gastrointestinal tract of humans and a wide range of animals. It is one of the most common enteric microorganisms with higher prevalence rates in developing than in developed countries. Feco-oral is the main route of transmission where low socioeconomic conditions, poor hygienic practices, close contact with animals, and drinking contaminated water act as major risk factors. Infection with Blastocystis was demonstrated in both symptomatic and asymptomatic people. For a long period, Blastocystis was considered a commensal organism with no pathogenic role, but recently, many studies linked it to different gastrointestinal symptoms such as nausea, diarrhea, and abdominal pain. Association with irritable bowel syndrome and colorectal cancer was also reported.

This study aims to:

  • Identify subtypes of human Blastocystis isolates in Sohag by using RFLP-PCR and provide additional information on the molecular epidemiology of this parasite in our locality.

Enrollment

100 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients from outpatient clinics, Sohag hospitals.

Exclusion criteria

  • Patients received antiparasitic drugs in the last two weeks

Trial contacts and locations

0

Loading...

Central trial contact

Shimaa Refaey Mohamed Abd-Elal, assistant lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems